INTRODUCTION {#S2}
============

Sleep is an ancient and conserved behavior, whose purpose remains largely unknown ([@R55]). Sleeping animals exhibit reduced motility, decreased responsiveness to the environment, and increased arousal thresholds ([@R4]), making them highly vulnerable to dangers such as predators. The benefits of sleep must, therefore, outweigh these considerable risks. Because sleep can be detrimental, the transitions in and out of this behavioral state must be prompt and tightly regulated. A number of mechanisms driving entry into and exit from sleep have been described. The circadian clock can influence sleep entry and recovery by regulating the activities of specific brain centers ([@R43]) or by controlling local brain circuits that collectively interact ([@R25]). Homeostatic drivers such as adenosine, which accumulates during wakefulness, have also been suggested to play roles in sleep/wakefulness transitions ([@R4]).

In 1895, Ramón y Cajal postulated in a theoretical paper that astrocytic glia might be global modulators of sleep ([@R16]; [@R40]). A number of recent studies experimentally support this view. Astrocytes appear to be required for switching cortical activities between awake and sleep states ([@R37]). Consistent with this, optogenetic activation of astrocytes enhances the sleep state ([@R35]), and this may occur through the release of adenosine ([@R19]) or by regulation of Notch signaling ([@R45]). Moreover, a number of studies implicate astrocytes in circadian behavior ([@R2]; [@R3]; [@R31]; [@R49]). Nonetheless, how sleep-promoting circuits are modulated by astrocytes to induce behavioral quiescence and whether this function is conserved is not clear.

A developmentally timed sleep-like state in the nematode *Caenorhabditis elegans* coincides with molting between larval stages ([@R39]), and it is termed lethargus. Molting onset, duration, and associated sleep are regulated by LIN-42/Period protein ([@R22]; [@R26]), whose homologs control circadian rhythms in insects and vertebrates. Like sleep in other animals, lethargus is characterized by behavioral quiescence, reduced sensory responsiveness, reversibility, homeostatic regulation, and stereotypical body posture ([@R7]; [@R21]; [@R27]; [@R39]; [@R44]). Several neurons have been implicated in *C. elegans* sleep and wakefulness, including the RMG, RIS, ALA, ASK, and RIA neurons, whose sleep-related activities involve responses to or release of specific neuropeptides ([@R8]; [@R28]; [@R29]; [@R50], [@R51]; [@R52]). Epidermal growth factor (EGF) and Notch signaling are also implicated in sleep control ([@R47]; [@R52]). Simultaneous imaging of nearly all *C. elegans* head neurons, using the calcium sensor GCaMP, reveals a reduction in activity of most neurons during lethargus ([@R32]).

The *C. elegans* nerve ring is a brain-like neuropil consisting of most axons in the animal and harboring the majority of neuron-neuron synapses. This structure is associated with four CEPsh glial cells. These glia share a number of features with vertebrate astrocytes. Like astrocytes, CEPsh glia tile around the brain neuropil to define non-overlapping domains ([@R34]; [@R53]). Within the neuropil, CEPsh glia en-sheath a well-defined set of synapses ([@R53]), resembling vertebrate tripartite synapses that consist of neuronal synaptic pairs and astrocyte processes ([@R18]). CEPsh glia also promote synaptogenesis ([@R10]), an important function of vertebrate astrocytes ([@R12]). During development, CEPsh glia transform from simple bipolar cells to highly branched cells, reminiscent of the radial glia-to-astrocyte transition in vertebrates ([@R41]). Importantly, CEPsh glia are enriched for gene transcripts also enriched in astrocytes, including the glial glutamate transporter *glt-1* (M.K., unpublished data) ([@R54]). Glia-specific loss of GLT-1 in both *C. elegans* and vertebrates results in repetitive behaviors (M.K., unpublished data) ([@R1]).

Here, we show that CEPsh glia are important regulators of sleep entry in *C. elegans*. Ablation of these glia results in precocious sleep bouts during lethargus, increased sleep duration, and transient locomotory pausing in adults. Furthermore, larval development in glia-ablated animals is considerably prolonged. Remarkably, inactivation of the ALA neuron, whose synapses with the postsynaptic AVE interneuron are ensheathed by CEPsh glia processes, is sufficient to reverse all of these defects. Epistasis studies reveal that ALA, AVE, and CEPsh glia act in the same circuit, and activity imaging in AVE suggests that loss of CEPsh glia decouples input and output signals in this neuron, in a manner dependent on ALA. Our data highlight a specific synaptic connection mediating locomotion inhibition during sleep and suggest an integral role for glia in modulating this connection.

RESULTS {#S3}
=======

CEPsh Glia Regulate Sleep Entry, Adult Locomotory Pausing, and the Rate of Development {#S4}
--------------------------------------------------------------------------------------

To determine whether *C. elegans* CEPsh glia play roles in sleep, we ablated all four cells in first-stage (L1) larvae, after nerve ring formation, using a reconstituted Caspase-3 gene expressed specifically in CEPsh glia ([@R6]) (M.K., unpublished data), and we assessed the effects on locomotion during the L4-to-adult molt. As previously reported ([@R39]), wild-type animals are constantly active during the intermolt period ([Figures 1A, 1C](#F1){ref-type="fig"}, and [S1A](#SD1){ref-type="supplementary-material"}) and exhibit a single consolidated episode of elevated locomotion quiescence during the molt ([Figures 1A, 1D](#F1){ref-type="fig"}, and [S1A](#SD1){ref-type="supplementary-material"}). However, the 3/3 CEPsh glia-ablated lines we generated experience ectopic quiescence bouts of \~20 min in duration, 1--2 hr before the beginning of a prolonged consolidated period of inactivity ([Figures 1B, 1C](#F1){ref-type="fig"}, and [S1A](#SD1){ref-type="supplementary-material"}). As in both wild-type and glia-ablated animals consolidated quiescence of \>2 hr is apparent, we define this period as lethargus. The shorter duration quiescence episodes preceding lethargus in glia-ablated animals are defined as precocious episodes. These observations demonstrate that CEPsh glia are required for regulating the transition between awake and sleep states. Consistent with these observations, we found that, in 2/3 glia-ablated lines, the main quiescence period is also prolonged ([Figures 1D](#F1){ref-type="fig"} and [S1A](#SD1){ref-type="supplementary-material"}), suggesting that ablated animals exhibit a general propensity for sleep.

We wondered, therefore, whether CEPsh glia-ablated animals might also exhibit locomotory quiescence during adulthood, when animals no longer molt. To test this, we tracked the foraging behavior of adult animals on agar plates in the absence of food and used a Hidden Markov Model to identify states of motion and quiescence based on animal velocity (Experimental Procedures; [Figures S1B--S1D](#SD1){ref-type="supplementary-material"}). We found that, while wild-type animals exhibit continuous movement on plates, CEPsh glia-ablated adults display periods of locomotory pausing, which are variable between individual animals and which can last from a few seconds to several minutes ([Figures 1E](#F1){ref-type="fig"}, [S1D, and S1E](#SD1){ref-type="supplementary-material"}; [Movies S1](#SD2){ref-type="supplementary-material"} and [S2](#SD3){ref-type="supplementary-material"}). Of note, while reduced pharyngeal pumping normally accompanies lethargus-associated sleep in *C. elegans*, pumping rates are not altered in CEPsh glia-ablated adults ([Figure S1F](#SD1){ref-type="supplementary-material"}). Thus, glia appear to specifically control locomotory aspects of sleep, consistent with previous studies reporting that locomotion and pharyngeal pumping quiescence are regulated by different pathways ([@R28]).

To determine whether the ectopic pre-lethargus quiescence and the adult locomotory pausing seen in CEPsh glia-ablated animals are functionally related to lethargus quiescence, we examined animals defective in EGL-4, a cyclic GMP-dependent protein kinase expressed in many head neurons and previously characterized as a general regulator of sleep ([@R39]). We examined animals carrying either a loss-of-function mutation (*ks62;* −) or a gain-of-function mutation (*ad450;* g) in the *egl-4* gene. We found that, in addition to reducing the quiescence fraction during lethargus ([Figure S1G](#SD1){ref-type="supplementary-material"}), loss of *egl-4*(−) also suppresses pre-lethargus quiescence and adult locomotory pausing in animals lacking CEPsh glia ([Figures 1F and 1G](#F1){ref-type="fig"}). Consistent with these observations, gain of EGL-4 function increases quiescence during lethargus and adult locomotory pausing in glia-ablated animals ([Figures 1G](#F1){ref-type="fig"} and [S1G](#SD1){ref-type="supplementary-material"}), although pre-lethargus quiescence was not affected in this mutant ([Figure 1F](#F1){ref-type="fig"}).

Although the mechanism of EGL-4 function is not well understood, our genetic results using *egl-4* mutants nonetheless suggest that the various forms of locomotion quiescence we examined are likely related.

Finally, in addition to ectopic sleep bouts, we also observed a considerable developmental delay in CEPsh glia-ablated animals, a defect shared with *egl-4*(g) mutants ([Figure S1H](#SD1){ref-type="supplementary-material"}). While freshly laid wild-type embryos develop to adulthood within \~55 hr at 20°C, more than 20% of CEPsh glia-ablated animals only reach the L4 or younger larval stages after a similar amount of time ([Figure 1H](#F1){ref-type="fig"}). This observation raises the possibility that increased somnolence slows development of the animal (see below).

Taken together, our data suggest that CEPsh glia normally block locomotory quiescence and that their absence promotes ectopic quiescence during and outside the period of lethargus.

Ectopic Locomotory Quiescence and Developmental Delay Require the ALA Neuron {#S5}
----------------------------------------------------------------------------

To understand how CEPsh glia block locomotory quiescence, we sought to identify neurons relevant to this glial function. In addition to ensheathing the nerve ring, CEPsh glia also send anterior processes that wrap around sensory endings of the dopaminergic CEP neurons. We found that ablation of CEP neurons in wild-type animals does not phenocopy CEPsh glia ablation and does not rescue ectopic locomotory pausing of CEPsh glia-ablated adults ([Figure S1I](#SD1){ref-type="supplementary-material"}). Thus, CEP neurons are unlikely to be the relevant targets of CEPsh glia in locomotion control.

Unlike most neurons, the ALA neuron remains active during sleep ([@R32]), and its optogenetic activation suppresses motion ([@R14]; [@R30]). Further-more, ALA has been suggested to promote sleep entry ([@R52]). To test if locomotion quiescence observed in glia-ablated animals involves ALA, we disrupted the cell by either laser ablation or by crossing to a *ceh-17(np1)* mutant, which perturbs ALA development and activity ([@R38]; [@R52]). While disruption of ALA has no effect on locomotion in wild-type adults, it significantly rescues the ectopic pausing episodes of CEPsh glia-ablated adults ([Figures 2A and 2B](#F2){ref-type="fig"}). Importantly, loss of ALA function also fully rescues the pre-lethargus quiescence episodes ([Figure 2C](#F2){ref-type="fig"}), the extended duration of lethargus ([Figure S2A](#SD1){ref-type="supplementary-material"}), and, remarkably, also the developmental delay ([Figure 2D](#F2){ref-type="fig"}) of CEPsh glia-ablated animals. That *ceh-17* mutants alone do not exhibit defects in sleep control suggests that other parallel pathways likely also act to induce developmentally regulated sleep in *C. elegans*.

Together, these results suggest that all forms of ectopic quiescence episodes in CEPsh glia-ablated animals are a consequence of inappropriate activity of ALA. Thus, CEPsh glia may normally act to block ALA.

Activation of LET-23/EGF receptor (EGFR) in ALA controls sleep induced by heat and other stressors ([@R20]; [@R52]). To determine if glial effects on locomotion quiescence involve EGF signaling, we examined CEPsh glia-ablated animals also defective in *let-23(sy12).* We found that these animals show enhanced pre-lethargus quiescence, prolonged lethargus duration, and increased locomotion pausing in adults, compared with CEPsh glia-ablated animals alone ([Figures S2B--S2D](#SD1){ref-type="supplementary-material"}). These observations suggest that LET-23 normally inhibits locomotory quiescence and that it can do so independently of CEPsh glia. Supporting this notion, ALA disruption does not significantly alleviate ectopic adult pausing of CEPsh glia-ablated animals also carrying a *let-23* mutation ([Figure S2D](#SD1){ref-type="supplementary-material"}). These results are consistent with previous reports suggesting that developmentally timed sleep and stress-induced sleep are regulated by different mechanisms ([@R48]).

The AVE Neuron Functions Downstream of ALA and CEPsh Glia for Locomotory Quiescence {#S6}
-----------------------------------------------------------------------------------

ALA has only five synaptic outputs, four of which target the backward locomotion command interneuron AVE, which synapses onto motor neurons ([@R5]; [@R53]). Three of the four ALA-AVE synapses are ensheathed by CEPsh glia processes, and they represent one of only two classes of such tripartite synapses known in *C. elegans* ([@R53]). These observations raise the possibility that AVE may be a relevant target for ALA during locomotion quiescence. To test this idea, we generated animals expressing tetanus toxin, which blocks synaptic neurotransmitter release, under the control of an AVE-specific promoter. These animals exhibit twitching movements primarily at the nose and tail tips (as opposed to locomotion) during lethargus, which prevented us from reliably assaying quiescence behavior during the sleep period ([Figures S3A and S3B](#SD1){ref-type="supplementary-material"}). However, we were able to follow ectopic locomotory pausing in adults. We found that, as with CEPsh glia ablation, AVE inhibition results in ectopic pausing ([Figure 3A](#F3){ref-type="fig"}). By contrast, disruption of ALA does not rescue this pausing ([Figure 3A](#F3){ref-type="fig"}). Importantly, ablation of both AVE and CEPsh glia does not enhance pausing beyond what is observed for CEPsh ablation alone ([Figure 3B](#F3){ref-type="fig"}). Thus, AVE appears to function in the same circuit as and downstream of ALA and CEPsh glia in locomotion quiescence.

Since CEPsh glia ensheath ALA-AVE synapses, we wondered whether CEPsh loss may affect the structural integrity of these synapses. To test this, we generated animals expressing separate components of membrane-localized split-GFP ([@R13]) in ALA and AVE, using non-overlapping cell-specific promoters, and assessed membrane juxtaposition by GFP fluorescence. AVE postsynaptic sites were marked in these animals with mCherry-tagged neuroligin ([Figure S3C](#SD1){ref-type="supplementary-material"}). We found a comparable percentage of animals with intact synapses in wild-type and CEPsh glia-ablated animals (47% and 58%, respectively; n \> 90). These results suggest that the effects of CEPsh glia removal are unlikely to be structural and may be a result of altered synaptic activity.

CEPsh Glia and ALA Control Coupling between AVE Calcium Elevation and Backward Locomotion {#S7}
-----------------------------------------------------------------------------------------

To study whether CEPsh glia affect AVE activity, we generated animals expressing the fluorescent calcium reporter GCaMP in AVE and confined them to a narrow trap in which they were able to move their head for short distances back and forth ([@R9]). In this assay, frequent changes in AVE calcium levels and in head position are observed ([Figures S4A and S4B](#SD1){ref-type="supplementary-material"}; [Movie S3](#SD4){ref-type="supplementary-material"}). We classified AVE activity into four states, ramping up, ramping down, and high or low plateaus, and analyzed the transition between these states using a Hidden Markov Model ([Figures S4C and S4D](#SD1){ref-type="supplementary-material"}) ([@R23]). This analysis revealed a strong correlation between calcium increases in AVE and backward retraction of the head in wild-type animals ([Figures 4A--4C](#F4){ref-type="fig"}). Calcium increases in AVE were previously shown to correlate with reversal movements ([@R24]), suggesting that head retraction in our device likely indicates an intended reversal attempt. Importantly, the association between head movement and calcium activity is degraded in CEPsh glia-ablated animals ([Figure 4B](#F4){ref-type="fig"}). Indeed, in CEPsh glia-ablated animals, \>20% of calcium events are not accompanied by backward head retractions at all (error events; [Figures 4C](#F4){ref-type="fig"}, [S4E, and S4F](#SD1){ref-type="supplementary-material"}). Moreover, while CEPsh glia-ablated and wild-type animals exhibit similar average AVE calcium amplitudes ([Figure 4A](#F4){ref-type="fig"}) and frequencies ([Figure S4G](#SD1){ref-type="supplementary-material"}), the fraction of time AVE is in an active (on) state is significantly increased in CEPsh glia-ablated animals ([Figure 4D](#F4){ref-type="fig"}).

To determine whether changes in AVE calcium dynamics are related to the ALA-AVE synapses ensheathed by CEPsh glia, we assayed AVE calcium activity in CEPsh glia-ablated animals carrying the *ceh-17* mutation. As shown in [Figures 4A--4D](#F4){ref-type="fig"}, ALA inhibition is sufficient to restore normal AVE calcium peak duration and correlation with head movement to CEPsh glia-ablated animals. Thus, CEPsh glia control of AVE functional output requires ALA.

We wondered whether the prolonged calcium peaks and the decoupling of AVE activation from backward head movement are related defects. To test this, we examined AVE calcium levels in animals expressing tetanus toxin in AVE. We found that, by blocking AVE synaptic release, the mean duration of calcium signals is prolonged, as with CEPsh glia-ablated animals ([Figure 4D](#F4){ref-type="fig"}). These results suggest that the prolonged AVE calcium peaks observed in CEPsh glia-ablated animals could be a result of inhibition of AVE synaptic output.

Our data suggest that the synapses between ALA and AVE are unusual. Activation of these inhibitory synapses blocks AVE output, but not by reducing AVE excitability, as the frequency and amplitude of AVE calcium peaks are not perturbed in CEPsh glia-ablated animals. We wondered, therefore, whether standard neurotransmitter signaling occurs at ALA-AVE synapses. We examined mutations in different neurotransmitter and neuropeptide pathways and assessed whether these can rescue the ectopic pausing episodes of adult CEPsh-ablated animals, as do mutations in *ceh-17* or ALA ablation. Some mutants we tested confer pausing behavior independently of glia ablation. For these, we assessed the ability to rescue the developmental delay of CEPsh-ablated animals. As summarized in [Table S1](#SD5){ref-type="supplementary-material"}, mutations affecting dopamine (*cat-2*), serotonin (*tph-1*), and glutamate (*eat-4*) signaling fail to rescue pausing, as does a mutation in *snf-11*, the transporter required for GABA accumulation in ALA ([@R17]). Acetylcholine (ACh) mutants could not be tested, as they exhibit greatly reduced locomotion and strong developmental delays; however, ALA does not express canonical ACh synthesis or uptake proteins ([@R36]). Thus, ACh is likely not involved.

To examine the involvement of neuropeptide signaling, we tested mutations in genes controlling dense-core vesicle fusion (*unc-31* and *ida-1*) or neuropeptide maturation (*egl-21*/carboxy-peptidase E and *aex-5*, *egl-3*, *kpc-1*, and *bli-4* peptide convertases). Only *aex-5* mutants show moderate rescue, possibly suggesting the involvement of neuropeptide signaling. We therefore examined mutations in neuropeptide/receptor genes that are highly enriched in ALA ([@R28]) or that have been previously associated with sleep regulation (*flp-7*, *flp-13*, *flp-24*, *nlp-8*, [@R28]; sNPF/*flp-27*, [@R46]; and *npr-22* implicated in the response of ALA to the RIS-released neuropeptide FLP-11, [@R51]). However, no suppression of CEPsh glia ablation defects was found. Pausing is markedly reduced by mutation in *npr-1*, a neuropeptide Y receptor implicated in lethargus ([@R8]). However, we found that NPR-1 expression in sensory neurons ([@R8]) is sufficient to restore ectopic pausing ([Table S1](#SD5){ref-type="supplementary-material"}), indicating that, at least in part, neuropeptide signaling can function upstream of the ALA-AVE synapse to control ectopic pausing.

Our results, therefore, eliminate most non-peptidergic neurotransmitter pathways as relevant for ALA-AVE synaptic function and suggest that either unknown *aex-5*-dependent neuropeptides or non-canonical signals mediate AVE synaptic inhibition by ALA.

DISCUSSION {#S8}
==========

Except for dwelling episodes associated with food ([@R15]), stress ([@R20]), and molting ([@R39]), the free-living nematode *C. elegans* continually moves. Here, we find that CEPsh glia of this animal control the transition into locomotion quiescence in the context of sleep. Importantly, glia are involved in sleep regulation in mice ([@R19]; [@R35]) and flies ([@R45]), indicating an evolutionarily conserved function for this cell class.

Our results suggest a model ([Figure 4E](#F4){ref-type="fig"}) in which CEPsh glia block an inhibitory synapse between the ALA and AVE neurons. Removal of CEPsh glia allows ALA to promote AVE inactivation, not by hyperpolarizing AVE but by uncoupling its synaptic input from its synaptic output.

Loss of CEPsh glia results in precocious episodes of quiescence immediately preceding lethargus in an ALA neuron-dependent manner. This unusual quiescence profile raises the possibility that sleep initiation may be governed by a gradual accumulation of sleep factors past a threshold, driving quiescence. Glia can serve to uptake a variety of neurotransmitters and secreted proteins from their surroundings ([@R11]; [@R42]), and it could therefore be that secreted moieties are relevant sleep factors. In this scenario, in CEPsh glia-ablated animals, the threshold for sleep entry is lowered by ectopic accumulation of sleep-inducing factors, resulting in premature sleep onset. Such a model may also explain the slower recovery from lethargus in CEPsh glia-ablated animals. A threshold model predicts that other sleep factors independent of CEPsh glia exist, as pre-lethargus quiescence episodes are transient and not consolidated as the main lethargus bout. Supporting this prediction, the ALA-dependent narcoleptic-like pausing behavior in CEPsh glia-ablated adults uncouples locomotion quiescence from other aspects of sleep, such as pharyngeal pumping. These findings not only suggest that sleep is a sum of different processes controlled by different pathways, but also implicate CEPsh glia and the ALA-AVE synapses they ensheath specifically in locomotion quiescence.

Only one other synaptic pairing is documented to be tightly ensheathed by CEPsh glia. This pairing, between the AIN and BAG presynaptic and postsynaptic neurons ([@R53]), is not known to have roles in sleep control. Nonetheless, the tight ensheathment may reflect an important synaptic function for glia that is not needed elsewhere. Indeed, our studies suggest that the ALA-AVE synapses may be atypical in other ways. Loss of CEPsh glia perturbs AVE functional output (reversal movement) in a manner dependent on ALA, but it affects neither the amplitude nor the frequency of AVE activation in our experimental setup. Such uncoupling of calcium induction and synaptic output has been previously reported in the ASER neuron of *C. elegans* in the context of a simple learning behavior. In that work, salt, which is usually attractive, becomes aversive when paired with starvation. Imaging of ASER reveals that salt cues usually induce calcium signals that drive synaptic vesicle release. Following starvation, however, neuronal outputs are inhibited even though calcium signals are enhanced ([@R33]). Thus, in addition to exhibiting uncoupling of synaptic input and output, inhibition of ASER by starvation and of AVE by CEPsh glia ablation are associated with increased calcium signal in these cells, suggesting the possibility of common, yet still unknown, underlying mechanisms.

It is of note that the ALA-AVE synapses are the most cell body-proximal synapses on AVE neurites ([@R53]). Whether this anatomical configuration reflects on the mechanism by which synaptic input and output are uncoupled in this neuron is unclear. Understanding the molecular nature of ALA-AVE neurotransmission should greatly aid in understanding how CEPsh glia inhibition of this synapse works. We have been able to eliminate most neurotransmitter classes and some ALA-expressed neuropeptides; however, peptidergic transmitters could still be relevant.

Finally, whether CEPsh glial activities in the context of sleep are dynamically modulated or whether these cells establish a fixed set point for neuronal activity that is not altered during the animal's life remains unknown. Identification of mediators of glial function and assessment of temporal changes in their activities, or lack thereof, will allow this question to be addressed.

EXPERIMENTAL PROCEDURES {#S9}
=======================

For strains and plasmids used in this study as well as detailed descriptions of GFP reconstitution across synaptic partners (GRASP) signal acquisition and scoring, cell ablation, and development scoring, see the [Supplemental Experimental Procedures](#SD1){ref-type="supplementary-material"}.

Locomotion Analysis {#S10}
-------------------

First-day adults were washed off food and transferred to a 6-cm nematode growth media (NGM)-agar plate with a high-osmolarity barrier (4M Fructose) at the plate periphery to prevent wandering of animals off the plate. Animals were allowed to adjust to the plate for 20 min, and locomotion was recorded using a camera for 30 min at 2 frame/s. Custom Java scripts identified and tracked moving animals and analyzed worm pausing behaviors (see the [Supplemental Experimental Procedures](#SD1){ref-type="supplementary-material"} for more details). The fraction of the total time animals were found pausing in all tracks relative to the overall duration of all the tracks in a movie was used to calculate the percentage of time adult animals spent pausing.

Lethargus Behavior {#S11}
------------------

Intermolt and lethargus quiescence assays were performed in artificial dirt poly-dimethylsiloxane (PDMS) chips as previously described ([@R21]), except that mid-L4 larvae were picked from a population of mixed-stage animals according to their morphology, and behavior was recorded for 10 hr. Generally, the onset of lethargus was defined as the first time point from which the fraction of quiescence remained above 5% for 20 consecutive min; for animals displaying substantial pre-lethargic quiescence, the starting point for the quiescence threshold search was determined manually based on the quiescence profile (see the [Supplemental Experimental Procedures](#SD1){ref-type="supplementary-material"} for more details).

Analysis of AVE Activity and Response {#S12}
-------------------------------------

Calcium imaging from the AVE neuron was performed using a microfluidic device as described ([@R9]). Images were captured for 5 min at 4 frames/s and analyzed using a custom Java code for AVE activity and position within the microfluidic device (see the [Supplemental Experimental Procedures](#SD1){ref-type="supplementary-material"} for more details).

Statistics {#S13}
----------

ANOVA Tukey's honest significant difference (HSD) post hoc test was used in the behavioral and developmental assays for comparison of multiple populations of animals using an R script with the null hypothesis that all samples are similar. Random permutation tests were used to evaluate the significance of differences in AVE activity and worm response between worm populations, using a Java code. Consider two sets of recordings from individual worms, *n*~1~ from population 1 and *n*~2~ from population 2. Each recording, which can comprise multiple AVE activation events, is treated as an independent sample. To test the null hypothesis that the two worm populations are equivalent, a large number (10^5^) of random rearrangements of the two sets of samples into two groups of sizes *n*~1~ and *n*~2~ is generated. The stated significance figures are obtained as the fraction of the rearrangements for which the difference in the quantity of interest (fraction of error events or fraction of the time in the "on" state) between the rearranged groups is at least as large as the difference between the original groups. Unpaired two-sided Student's t test was used to determine the statistical significance between glia-ablated and non-ablated animals that are mutated for the various neurotransmitter and neuropeptide pathways.

Supplementary Material {#S15}
======================
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![Post-embryonic Ablation of CEPsh Glia Affects Sleep Entry, Locomotion, and Development\
(A and B) Traces of the quiescence fraction (Experimental Procedures) during the L4-adult transition of a wild-type (A) or a CEPsh glia-ablated (B) animal. Lethargus onset occurs at t = 0.\
(C and D) Average quiescence fraction 4 hr before (C) and after (D) lethargus initiation, binned in 1-hr intervals. WT, wild-type. GA, glia ablated. Error bars indicate SE. Number of animals is indicated within or above each bar.\
(E) Ablation of CEPsh glia results in enhanced pausing (n = 5 movies). Vertical axis represents the percentage of total time animals spent pausing out of the total duration of all recorded tracks.\
(F and G) EGL-4 affects pre-lethargus quiescence (F) and ectopic adult pausing (G; n = 3 movies) of CEPsh glia-ablated animals (GA1). Loss-of-function mutation, −/lof; gain-of-function mutation, g/gof.\
(H) Percentage of animals reaching a given developmental stage 55 hr after embryos are laid. Experiments were done in triplicate.\
(C--H) Bar graphs, mean ± SEM; ANOVA Tukey's HSD post hoc test, ^\*^compared to WT, \^compared to glia-ablated line 1; number of symbols represents (1) p \< 0.05 and (3) p \< 0.0005.\
See also [Figure S1](#SD1){ref-type="supplementary-material"}.](nihms952014f1){#F1}

![CEPsh Glia Ablation Defects Are Rescued by Disrupting ALA\
(A) Ectopic pausing of CEPsh glia-ablated adults is suppressed by ALA ablation (−) (n = 2 movies). Details are as in [Figure 1E](#F1){ref-type="fig"}.\
(B) A *ceh-17* loss-of-function (−) mutation also suppresses ectopic pausing of CEPsh glia-ablated adults (n = 4 movies). Details are as in [Figure 1E](#F1){ref-type="fig"}.\
(C) A *ceh-17* mutation (−) suppresses ectopic pre-lethargus quiescence in CEPsh glia-ablated animals. Details are as in [Figure 1G](#F1){ref-type="fig"}.\
(D) A *ceh-17* mutation (−) restores normal development of CEPsh glia-ablated animals (experiments done in triplicate).\
(A--D) Bar graphs, mean ± SEM; ANOVA Tukey's HSD post hoc test, \*compared to WT, \^compared to glia-ablated parent; number of symbols represents (1) p \< 0.05, (2) p \< 0.005, and (3) p \< 0.0005.\
See also [Figure S2](#SD1){ref-type="supplementary-material"}.](nihms952014f2){#F2}

![AVE Functions with ALA and CEPsh Glia to Control Locomotory Pausing\
(A) Expression of tetanus toxin (TeTx) in AVE promotes ectopic pausing in adults, which is not rescued by a *ceh-17* mutation (−) (n = 3 movies). Details are as in [Figure 1E](#F1){ref-type="fig"}.\
(B) Ablation of AVE (−) does not enhance pausing of CEPsh-ablated worms (n = 2 movies). Details are as in [Figure 1E](#F1){ref-type="fig"}.\
(A and B) Bar graphs, mean ± SEM; (A) ANOVA Tukey's HSD post hoc test, \*compared to WT; number of symbols represents (1) p \< 0.05 and (3) p \< 0.0005.\
See also [Figure S3](#SD1){ref-type="supplementary-material"}.](nihms952014f3){#F3}

![CEPsh Glia and ALA Affect AVE Calcium Signal Duration and Behavioral Output\
(A) Average of AVE GCaMP signals, the number of total events analyzed for each strain is indicated on the graph. Dashed gray line, GCaMP signal rise initiation. All strains contain a GCaMP2.2 transgene.\
(B) Head position relative to AVE GCaMP signal rise initiation (dashed gray line). Forward and backward head locations were determined by AVE cell body position.\
(C) Percentage of events in which AVE GCaMP signal increase is not followed by backward head movement. Number of animals is indicated within or above each bar. (A--C) Error bars, mean ± SEM.\
(D) The mean fraction of the time AVE calcium signal is at the high plateau "on" state (Experimental Procedures) is prolonged in CEPsh-ablated and AVE-TeTx animals. Number of animals is indicated within or above each bar. (C and D) \*p \< 0.01, random permutation test.\
(E) Model for CEPsh glia function. CEPsh glia negatively regulate the inhibitory signaling between ALA and AVE.\
See also [Figure S4](#SD1){ref-type="supplementary-material"}.](nihms952014f4){#F4}

###### Highlights

-   *C. elegans* CEPsh glia modulate locomotory quiescence during sleep

-   Glia attenuate sleep-promoting inhibitory synapses between ALA and AVE neurons

-   ALA promotes uncoupling of calcium transients and synaptic output in AVE
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